Vimarsana
Biggest News Aggregation in the World

Page 17 - Webcast Today News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Webcast Today. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Webcast Today Today - Breaking & Trending Today

Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer - Vimarsana News

Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer

Share: U.S. FDA Granted Fast Track Designation in 2018 Trial Expected to Enroll 300-400 Patients at Approximately 165 Sites in the U.S. and Europe in Simplified Adaptive Trial Design Conference Call and Webcast Today at 8:30 a.m. ET HOUSTON, April 27, 2021 (GLOBE NEWSWIRE) -- Aravive Inc. (NASDAQ:ARAV), a clinical-stage oncology company developing innovative therapeutics to treat life-threatening diseases, today announced the Company has dosed the first patient in its Phase 3 trial of AVB-500 in platinum resistant ovarian cancer (PROC). The trial is evaluating the efficacy of AVB-500 in com...

Zai Lab Announces Financial Results for Second-half and Full-year 2020 - Vimarsana News

Zai Lab Announces Financial Results for Second-half and Full-year 2020

Zai Lab Announces Financial Results for Second-half and Full-year 2020 March 01, 2021 07:00 ET | Source: Zai Lab Limited Zai Lab Limited -- Company to Host Conference Call and Webcast Today at 8:00 a.m. ET SHANGHAI and SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today reported financial results for the second half and full year of 2020, along with corporate updates. “2020 was another year of great accomplishment for Zai Lab,” said Dr. Samantha Du, Founder,...

Neurocrine Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results - Vimarsana News

Neurocrine Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results

Conference Call and Webcast Today at 4:30 PM Eastern Time Neurocrine Biosciences will hold a live conference call and webcast today at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). Participants can access the live conference call by dialing 800-895-3361 (US) or 785-424-1062 (International) using the conference ID: NBIX. The webcast can also be accessed on Neurocrine Biosciences' website under Investors at www.neurocrine.com. A replay of the webcast will be available on the website approximately one hour after the conclusion of the event and will be archived for approximately one month. Abo...

Zynerba Pharmaceuticals Provides Regulatory Update on Zygel™ in Fragile X Syndrome - Vimarsana News

Zynerba Pharmaceuticals Provides Regulatory Update on Zygel™ in Fragile X Syndrome

Zynerba Pharmaceuticals Provides Regulatory Update on Zygel™ in Fragile X Syndrome – Single Trial to be Conducted in Patients with Fragile X Syndrome to Confirm Positive Results Seen in the Population of Responders in the CONNECT-FX Trial – – Conference Call and Webcast Today, December 17, 2020 at 8:30 am ET – DEVON, Pa., Dec. 17, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today provided an update on its meeting with the ...